Table 7 Prognostic value of ALBI, MELD, MELD sarcopenia, and ALBI-Sarcopenia score to predict response to treatment.

From: ALBI-sarcopenia score as a predictor of treatment outcomes in hepatocellular carcinoma

  

AUC

P

95% C. I

Cut off

Sensitivity

Specificity

PPV

NPV

At 1 month

(n = 190 vs. 72)

ALBI

0.586

0.033*

0.507–0.664

≤ – 2.01#

62.11

56.94

79.2

36.3

MELD Sarcopenia

0.609

0.006*

0.533–0.685

≤ 18#

67.37

52.78

79.0

38.0

ALBI-Sarcopenia

0.628

0.001*

0.552–0.704

≤ – 10.18

62.63

58.33

79.9

37.2

Sarcopenia

0.0606

0.001*

0.508–0.644

 

62.11

56.94

79.19

36.28

AFP

0.701

< 0.001*

0.629–0.773

≤ 56.5

67.37

65.28

83.7

43.1

  1. AUC: Area Under a Curve, p-value: Probability value, CI: Confidence Intervals, NPV: Negative predictive value, PPV: Positive predictive value, *: Statistically significant at p ≤ 0.05, #Cut off was choose according to Youden index.